|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Key: Meeting
Showing releases 176-200 out of 952. << < 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 > >>
Public Release: 19-Dec-2012
 Cell MetabolismNTU study finds ways to prevent muscle loss, obesity and diabetes A research study from Nanyang Technological University has yielded important breakthroughs on how the body loses muscle, paving the way for new treatments for aging, obesity and diabetes. Contact: Lester Kok
Public Release: 18-Dec-2012
BMC Evolutionary BiologyTracking the origins of HIV Human immunodeficiency virus may have affected humans for much longer than is currently believed. Alfred Roca, an assistant professor in the College of Agricultural, Consumer and Environmental Sciences at the University of Illinois, thinks that the genomes of an isolated West African human population provide important clues about how the disease has evolved. 
Bill and Melinda Gates Foundation
Contact: Susan Jongeneel
Public Release: 18-Dec-2012
PLOS MedicineLittle evidence to support TB interventions in real-world, low-resource settings There is little evidence from real world situations in low-and-middle income countries to support the effectiveness and financial value of five interventions recommended by the World Health Organization to control tuberculosis, which may be a reason why these interventions have not been implemented in many countries, according to a study by international experts published in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 17-Dec-2012
Proceedings of the National Academy of SciencesUniv. of MD School of Medicine to study drug-resistant malaria in Myanmar University of Maryland School of Medicine researchers have launched research into the spread of potentially deadly drug-resistant malaria in the Southeast Asian nation of Myanmar, or Burma. The scientists have identified several promising genetic markers for the newest type of drug-resistant malaria in Southeast Asia, including Myanmar. Two new National Institutes of Health awards to the University of Maryland are some of the first U.S. federal funds to support the study of malaria in Myanmar. Contact: Karen Robinson
Public Release: 17-Dec-2012
Grant funded to improve mothers' nutrition before pregnancy and impact on baby The Regents of the University of Colorado are pleased to announce that the University of Colorado have been awarded a grant by the Bill & Melinda Gates Foundation. The grant, in the amount of more than $11 million, is to support research to normalize early growth of offspring of mothers in poor communities with high rates of early growth retardation.
Bill & Melinda Gates Foundation
Contact: Jackie Brinkman
Public Release: 17-Dec-2012
PLOS Neglected Tropical DiseasesChances seen rising for chikungunya outbreaks in NYC, Atlanta, Miami Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model that predicts outbreaks of chikungunya, a painful virus transported by travelers and spread by the invasive Asian tiger mosquito, could occur in 2013 in New York City during August and September, in Atlanta from June through September, and year-round in Miami.
National Institute for Food and Agriculture Hatch grant
Contact: John Carberry
Public Release: 17-Dec-2012
Journal of Biosocial ScienceFather's death affects early adolescents' futures in developing world A father's death can have long-term effects on a child's later success in life and can be particularly harmful if the father passes away during a child's late childhood or early adolescence, according to new research by a University of Missouri anthropologist. Recognizing the impact that a father's death can have on adolescents could lead to improved counseling and assistance programs, especially for needy families in the developing world. Contact: Tim Wall
Public Release: 17-Dec-2012
World Review of Science, Technology and Sustainable DevelopmentA layer of cool, healthy air Stratum ventilation systems have been touted as a much more energy efficient system for cooling buildings such as school rooms and offices in hotter climes based on the provisions of the recent ANSI/ASHRAE 55-2010. They may also reduce the risk of the spread of airborne diseases according to a study to be published early next year in the journal World Review of Science, Technology and Sustainable Development. Contact: Albert Ang
Public Release: 14-Dec-2012
eLifeWe're all living longer, but longevity increases not benefitting everybody Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground. Contact: Terry Lavender
Public Release: 13-Dec-2012
Agricultural, health education goes global via cellphone animations Many people in developing countries have cellphones that allow them to watch videos and play interactive games. Now agricultural researchers and health educators are using this technology to help those in the developing world address some of the most challenging issues they face -- and at a fraction of the cost of traditional development aid education.
ADM Institute for Post-harvest Losses at University of Illinois
Contact: Diana Yates
Public Release: 13-Dec-2012
Lives in the Balance: Delivering Medical Innovations for Neglected Patients and PopulationsMillions of patients still waiting for medical 'breakthroughs' against neglected diseases Despite important progress in research and development for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the "fatal imbalance" between global disease burden and drug development, said Doctors Without Borders/Médecins Sans Frontières and the Drugs for Neglected Diseases initiative, in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases. Contact: Oliver Yun
Public Release: 13-Dec-2012
LancetStudy finds years living with disease, injury increasing globally No matter where they live, how much education they have, or what their incomes are, people have similar perceptions on the impact of diseases and injuries. This finding is part of a collaborative project, the Global Burden of Disease Study 2010. Launched by Harvard School of Public Health, Institute for Health Metrics and Evaluation at the University of Washington, and 300 institutions worldwide, GBD 2010 is the single largest scientific effort ever conducted to quantify levels and trends in health worldwide.
Bill & Melinda Gates Foundation
Contact: Marge Dwyer
Public Release: 13-Dec-2012
PLOS PathogensEbola virus uses a protein decoy to subvert the host immune response In a study published today in the open-access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its infected host. Contact: Gina Alvino
Public Release: 13-Dec-2012
LancetBlood pressure, smoking and alcohol: The health risks with the biggest global burden Over 9 million people died as a consequence of high blood pressure in 2010, making it the health risk factor with the greatest toll worldwide, say experts. Contact: Sam Wong
Public Release: 13-Dec-2012
ImmunityNew study brings long-sought vaccines for deadly parasite closer to reality One major cause of illness from food-borne diseases is the parasite Toxoplasma gondii (T. gondii). New insights into how the immune system combats T. gondii are provided in a study published by Cell Press December 13th in the journal Immunity. The findings could lead to the development of long-sought vaccines to protect against T. gondii and related parasites. Contact: Mary Beth OLeary
Public Release: 12-Dec-2012
American Journal of Tropical Medicine and HygieneCeramic indoor cookstove use did not significantly lower child pneumonia risk in rural Kenya Inexpensive, locally produced ceramic cookstoves may produce less smoke than traditional indoor three-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya. Contact: Preeti Singh
Public Release: 12-Dec-2012
PLOS BiologyUGA researchers find algal ancestor is key to how deadly pathogens proliferate Long ago, when life on Earth was in its infancy, a group of small single-celled algae propelled themselves through the vast prehistoric ocean by beating whip like tails called flagella. It's a relatively unremarkable tale, except that now, more than 800 million years later, these organisms have evolved into parasites that threaten human health, and their algal past in the ocean may be the key to stopping them. Contact: Boris Striepen
Public Release: 11-Dec-2012
DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its pediatric HIV program.
UNITAID
Contact: Violaine Dallenbach
Public Release: 11-Dec-2012
New tuberculosis drug trial begins in South Africa Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis, including patients with HIV co-infection. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases
Contact: Jessica Studeny
Public Release: 11-Dec-2012
mBioNIH scientists reflect on gains in emerging infectious disease awareness, research and response In a new essay, National Institute of Allergy and Infectious Diseases director Anthony S. Fauci, M.D., and David Morens, M.D., reflect on what has been learned about emerging infectious diseases in the two decades since a major report from the US Institute of Medicine rekindled interest in this important topic.
NIH/National Institute of Allergy and Infectious Diseases
Contact: Anne A. Oplinger
Public Release: 11-Dec-2012
PLOS MedicineLong-term public health support needed to tackle infectious disease outbreaks Outbreaks of infectious diseases, such as swine flu (H1N1) threaten global health and should be considered by funding agencies and humanitarian organizations as development issues rather than emergency situations, requiring long-term support and investment, according to US experts writing in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 6-Dec-2012
New oral drug candidate for African sleeping sickness A new oral-only treatment for sleeping sickness has entered Phase II/III clinical study in patients with late-stage sleeping sickness in the Democratic Republic of the Congo and soon in Central African Republic. The study, initiated by the Drugs for Neglected Diseases initiative and its partners, will test the efficacy and safety of fexinidazole, with once-daily tablets for ten days. Contact: Violaine Dällenbach
Public Release: 5-Dec-2012
ScienceX-ray laser helps slay parasite that causes sleeping sickness An international team of scientists, using the world's most powerful X-ray laser, has revealed the 3D structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans. With the elucidation of the 3D structure of the cathepsin B enzyme, it will be possible to design new drugs to inhibit the parasite that causes sleeping sickness, leaving the infected human unharmed.
Department of Energy
Contact: Jenny Green
Public Release: 5-Dec-2012
Acta BiomaterialiaNew technique to deliver stem cell therapy may help damaged eyes regain their sight Engineers at the University of Sheffield have developed a new technique for delivering stem cell therapy to the eye which they hope will help the natural repair of eyes damaged by accident or disease. This could help millions of people across the world retain – or even regain - their sight.
Engineering & Physical Sciences Research Council, Wellcome Trust
Contact: Abigail Chard
Public Release: 4-Dec-2012
Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB Scientists at Albert Einstein College of Medicine of Yeshiva University have been awarded two Grand Challenges Explorations grants from the Bill & Melinda Gates Foundation for their innovative global health and development research projects.
Bill & Melinda Gates Foundation
Contact: Kim Newman
Showing releases 176-200 out of 952. << < 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 > >>
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||
|
|
 |
|
